Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Connelly

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Human Molecular Genetics|December 10, 2015
The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndromeKyla Brown, Jim Selfridge, Sabine Lagger, et al.
British Journal of Clinical Pharmacology|September 20, 2016
Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 yearsFrancesco Bellanti, Giovanni C Del Vecchio, Maria C Putti, et al.
Investigative Ophthalmology & Visual Science|November 6, 2010
The oral iron chelator deferiprone protects against iron overload-induced retinal degenerationMajda Hadziahmetovic, Ying Song, Natalie Wolkow, et al.
Translational Vision Science & Technology|September 20, 2013
The Oral Iron Chelator Deferiprone Protects Against Retinal Degeneration Induced through Diverse MechanismsMajda Hadziahmetovic, Miroslav Pajic, Steven Grieco, et al.
Translational Vision Science & Technology|September 20, 2013
The Oral Iron Chelator Deferiprone Protects Against Retinal Degeneration Induced through Diverse MechanismsMajda Hadziahmetovic, Miroslav Pajic, Steven Grieco, et al.
Scientific Reports|October 10, 2022
Metagenomic DNA sequencing to quantify Mycobacterium tuberculosis DNA and diagnose tuberculosisAdrienne Chang, Omary Mzava, Liz-Audrey Kounatse Djomnang, et al.
Scientific Reports|May 5, 2017
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's diseaseAntonio Martin-Bastida, Roberta J Ward, Rexford Newbould, et al.
Basic Research in Cardiology|March 7, 2020
Action of iron chelator on intramyocardial hemorrhage and cardiac remodeling following acute myocardial infarctionBita Behrouzi, Jill J Weyers, Xiuling Qi, et al.
Molecular Cancer Therapeutics|September 10, 2015
Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA ExpressionBeverly A Teicher, Eric Polley, Mark Kunkel, et al.
Clinical Epigenetics|June 27, 2020
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targetsJulia Krushkal, Thomas Silvers, William C Reinhold, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Human Molecular Genetics|December 10, 2015
The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndromeKyla Brown, Jim Selfridge, Sabine Lagger, et al.
British Journal of Clinical Pharmacology|September 20, 2016
Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 yearsFrancesco Bellanti, Giovanni C Del Vecchio, Maria C Putti, et al.
Investigative Ophthalmology & Visual Science|November 6, 2010
The oral iron chelator deferiprone protects against iron overload-induced retinal degenerationMajda Hadziahmetovic, Ying Song, Natalie Wolkow, et al.
Translational Vision Science & Technology|September 20, 2013
The Oral Iron Chelator Deferiprone Protects Against Retinal Degeneration Induced through Diverse MechanismsMajda Hadziahmetovic, Miroslav Pajic, Steven Grieco, et al.
Translational Vision Science & Technology|September 20, 2013
The Oral Iron Chelator Deferiprone Protects Against Retinal Degeneration Induced through Diverse MechanismsMajda Hadziahmetovic, Miroslav Pajic, Steven Grieco, et al.
Scientific Reports|October 10, 2022
Metagenomic DNA sequencing to quantify Mycobacterium tuberculosis DNA and diagnose tuberculosisAdrienne Chang, Omary Mzava, Liz-Audrey Kounatse Djomnang, et al.
Scientific Reports|May 5, 2017
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's diseaseAntonio Martin-Bastida, Roberta J Ward, Rexford Newbould, et al.
Basic Research in Cardiology|March 7, 2020
Action of iron chelator on intramyocardial hemorrhage and cardiac remodeling following acute myocardial infarctionBita Behrouzi, Jill J Weyers, Xiuling Qi, et al.
Molecular Cancer Therapeutics|September 10, 2015
Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA ExpressionBeverly A Teicher, Eric Polley, Mark Kunkel, et al.
Clinical Epigenetics|June 27, 2020
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targetsJulia Krushkal, Thomas Silvers, William C Reinhold, et al.
Pageof 5